2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide

C127H109N35O15 — CID 158598951

IUPAC2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide
SMILESCCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(/C=N/c4cc(C)[nH]n4)c3c2)c1.CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(C=Nc4ccn[nH]4)c3c2)c1.Cc1cc(/N=C/c2c(O)[nH]c3ccc(C(=O)c4cccc(NC(=O)c5nccn5C)c4)cc23)n[nH]1.Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(C=Nc5ccn[nH]5)c(O)[nH]c4c3)c2)n(C)n1.Cn1cc(C(=O)Nc2cccc(C(=O)c3ccc4[nH]c(O)c(C=Nc5ccn[nH]5)c4c3)c2)cn1
InChIInChI=1S/C27H25N7O3.C26H23N7O3.2C25H21N7O3.C24H19N7O3/c1-4-34-23(10-16(3)33-34)27(37)29-19-7-5-6-17(12-19)25(35)18-8-9-22-20(13-18)21(26(36)30-22)14-28-24-11-15(2)31-32-24;1-3-33-22(11-15(2)32-33)26(36)29-18-6-4-5-16(12-18)24(34)17-7-8-21-19(13-17)20(25(35)30-21)14-27-23-9-10-28-31-23;1-14-10-21(31-30-14)27-13-19-18-12-16(6-7-20(18)29-24(19)34)22(33)15-4-3-5-17(11-15)28-25(35)23-26-8-9-32(23)2;1-14-10-21(32(2)31-14)25(35)28-17-5-3-4-15(11-17)23(33)16-6-7-18-19(24(34)29-20(18)12-16)13-26-22-8-9-27-30-22;1-31-13-16(11-27-31)23(33)28-17-4-2-3-14(9-17)22(32)15-5-6-20-18(10-15)19(24(34)29-20)12-25-21-7-8-26-30-21/h5-14,30,36H,4H2,1-3H3,(H,29,37)(H,31,32);4-14,30,35H,3H2,1-2H3,(H,28,31)(H,29,36);3-13,29,34H,1-2H3,(H,28,35)(H,30,31);3-13,29,34H,1-2H3,(H,27,30)(H,28,35);2-13,29,34H,1H3,(H,26,30)(H,28,33)/b28-14+;;27-13+;;
InChIKeyPSHACBMEIHOTBI-MLQRNBJRSA-N
MW2365.50 g/mol
LogP20.33
Rot. Bonds32

About 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide

2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide (PubChem CID 158598951) has the molecular formula C127H109N35O15 and a molecular weight of 2365.50 g/mol. Its IUPAC name is 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide.

Molecular Properties

Compound Name2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide
PubChem CID158598951
Molecular FormulaC127H109N35O15
Molecular Weight2365.50 g/mol
Exact Mass2363.88
IUPAC Name2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide
SMILESCCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(/C=N/c4cc(C)[nH]n4)c3c2)c1.CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(C=Nc4ccn[nH]4)c3c2)c1.Cc1cc(/N=C/c2c(O)[nH]c3ccc(C(=O)c4cccc(NC(=O)c5nccn5C)c4)cc23)n[nH]1.Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(C=Nc5ccn[nH]5)c(O)[nH]c4c3)c2)n(C)n1.Cn1cc(C(=O)Nc2cccc(C(=O)c3ccc4[nH]c(O)c(C=Nc5ccn[nH]5)c4c3)c2)cn1
InChIInChI=1S/C27H25N7O3.C26H23N7O3.2C25H21N7O3.C24H19N7O3/c1-4-34-23(10-16(3)33-34)27(37)29-19-7-5-6-17(12-19)25(35)18-8-9-22-20(13-18)21(26(36)30-22)14-28-24-11-15(2)31-32-24;1-3-33-22(11-15(2)32-33)26(36)29-18-6-4-5-16(12-18)24(34)17-7-8-21-19(13-17)20(25(35)30-21)14-27-23-9-10-28-31-23;1-14-10-21(31-30-14)27-13-19-18-12-16(6-7-20(18)29-24(19)34)22(33)15-4-3-5-17(11-15)28-25(35)23-26-8-9-32(23)2;1-14-10-21(32(2)31-14)25(35)28-17-5-3-4-15(11-17)23(33)16-6-7-18-19(24(34)29-20(18)12-16)13-26-22-8-9-27-30-22;1-31-13-16(11-27-31)23(33)28-17-4-2-3-14(9-17)22(32)15-5-6-20-18(10-15)19(24(34)29-20)12-25-21-7-8-26-30-21/h5-14,30,36H,4H2,1-3H3,(H,29,37)(H,31,32);4-14,30,35H,3H2,1-2H3,(H,28,31)(H,29,36);3-13,29,34H,1-2H3,(H,28,35)(H,30,31);3-13,29,34H,1-2H3,(H,27,30)(H,28,35);2-13,29,34H,1H3,(H,26,30)(H,28,33)/b28-14+;;27-13+;;
InChIKeyPSHACBMEIHOTBI-MLQRNBJRSA-N
XLogP20.33
TPSA705.25 Ų
H-Bond Donors20
H-Bond Acceptors35
Rotatable Bonds32
Heavy Atoms177
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002365.50
LogP ≤ 520.33
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide?
The IUPAC name of 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide (CID 158598951) is 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide.
What is the SMILES notation for 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide?
The canonical SMILES for 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide is CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(/C=N/c4cc(C)[nH]n4)c3c2)c1.CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3[nH]c(O)c(C=Nc4ccn[nH]4)c3c2)c1.Cc1cc(/N=C/c2c(O)[nH]c3ccc(C(=O)c4cccc(NC(=O)c5nccn5C)c4)cc23)n[nH]1.Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(C=Nc5ccn[nH]5)c(O)[nH]c4c3)c2)n(C)n1.Cn1cc(C(=O)Nc2cccc(C(=O)c3ccc4[nH]c(O)c(C=Nc5ccn[nH]5)c4c3)c2)cn1.
What is the InChIKey of 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide?
The InChIKey is PSHACBMEIHOTBI-MLQRNBJRSA-N. The full InChI is InChI=1S/C27H25N7O3.C26H23N7O3.2C25H21N7O3.C24H19N7O3/c1-4-34-23(10-16(3)33-34)27(37)29-19-7-5-6-17(12-19)25(35)18-8-9-22-20(13-18)21(26(36)30-22)14-28-24-11-15(2)31-32-24;1-3-33-22(11-15(2)32-33)26(36)29-18-6-4-5-16(12-18)24(34)17-7-8-21-19(13-17)20(25(35)30-21)14-27-23-9-10-28-31-23;1-14-10-21(31-30-14)27-13-19-18-12-16(6-7-20(18)29-24(19)34)22(33)15-4-3-5-17(11-15)28-25(35)23-26-8-9-32(23)2;1-14-10-21(32(2)31-14)25(35)28-17-5-3-4-15(11-17)23(33)16-6-7-18-19(24(34)29-20(18)12-16)13-26-22-8-9-27-30-22;1-31-13-16(11-27-31)23(33)28-17-4-2-3-14(9-17)22(32)15-5-6-20-18(10-15)19(24(34)29-20)12-25-21-7-8-26-30-21/h5-14,30,36H,4H2,1-3H3,(H,29,37)(H,31,32);4-14,30,35H,3H2,1-2H3,(H,28,31)(H,29,36);3-13,29,34H,1-2H3,(H,28,35)(H,30,31);3-13,29,34H,1-2H3,(H,27,30)(H,28,35);2-13,29,34H,1H3,(H,26,30)(H,28,33)/b28-14+;;27-13+;;.
What are the key properties of 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide?
2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide has a molecular weight of 2365.50 g/mol, XLogP of 20.33, 32 rotatable bonds, 20 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 2-ethyl-N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;2-ethyl-N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-[(5-methyl-1H-pyrazol-3-yl)iminomethyl]-1H-indole-5-carbonyl]phenyl]-1-methylimidazole-2-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-6-carbonyl]phenyl]-2,5-dimethylpyrazole-3-carboxamide;N-[3-[2-hydroxy-3-(1H-pyrazol-5-yliminomethyl)-1H-indole-5-carbonyl]phenyl]-1-methylpyrazole-4-carboxamide is sourced from PubChem (CID 158598951), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).